| Dr Karen Sue Guest, PHD | |
|
108 E Clemmer Ave, Chamberlain, SD 57325-1308 | |
| (605) 734-6347 | |
| (605) 734-0577 |
| Full Name | Dr Karen Sue Guest |
|---|---|
| Gender | Female |
| Speciality | Psychologist |
| Location | 108 E Clemmer Ave, Chamberlain, South Dakota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073593844 | NPI | - | NPPES |
| 0003766 | Other | SD | WELLMARK BLUE CROSS BLUE |
| 6550760 | Medicaid | SD | |
| 21903 | Other | SD | SIOUX VALLEY HEALTH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | LMFT1161 (South Dakota) | Secondary |
| 103T00000X | Psychologist | 350 (South Dakota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Karen Sue Guest, PHD 108 E Clemmer Ave, Chamberlain, SD 57325-1308 Ph: (605) 734-6347 | Dr Karen Sue Guest, PHD 108 E Clemmer Ave, Chamberlain, SD 57325-1308 Ph: (605) 734-6347 |
News Archive
Idera Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing a novel therapeutic approach for the treatment of autoimmune diseases and genetically defined forms of B-cell lymphoma, today announced that enrollment is open for a Phase 1/2 clinical trial of IMO-8400 in patients with Waldenström's macroglobulinemia, following acceptance of its Investigational New Drug application by the U.S. Food and Drug Administration.
A new study by researchers at the Universities of Montana, Valle de México, Boise State, Universidad Veracruzana, Instituto Nacional de Pediatría and Paul-Flechsig-Institute for Brain Research heightens together with German company Analytik Jena concerns over the evolving and relentless Alzheimer's pathology observed in young Metropolitan Mexico City urbanites.
The European Society of Cardiology has launched a novel position paper, under the auspices of its Committee for Practice Guidelines, on tackling the cardiac toxicity of anticancer therapies. The cardio-oncology paper is published online today in European Heart Journal and on the ESC Website.
Most countries in the world are not publishing data disaggregated by sex, thereby putting a strain on efforts to improve gender equality, according to the latest Open Data Inventory.
In a very large cohort of African-American women in the US, the association between the consumption of alcohol, tea, and coffee and the development of type 2 diabetes mellitus (late onset diabetes) was studied for 12 years. Tea and decaffeinated coffee showed no relation with diabetes, but the regular moderate intake of both caffeinated coffee and alcohol appeared to reduce the risk of contracting late onset diabetes significantly.
› Verified 4 days ago